Dual Targeting of MAPK and PI3K Pathways Unlocks Redifferentiation of Braf-Mutated Thyroid Cancer Organoids

Using mESC-derived thyroid organoids, researchers developed a BrafV637E-inducible model able to recapitulate the features of papillary thyroid cancer in vitro.
Full ArticleGraphical Abstract

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News